Intratympanic gentamicin for Ménière's disease
is a topic covered in the Evidence-Based Medicine Guidelines
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
"Intratympanic Gentamicin for Ménière's Disease." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/451698/all/Intratympanic_gentamicin_for_Ménière's_disease.
Intratympanic gentamicin for Ménière's disease. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/451698/all/Intratympanic_gentamicin_for_Ménière's_disease. Accessed October 22, 2019.
Intratympanic gentamicin for Ménière's disease. (2019). In Evidence-Based Medicine Guidelines. Available from https://evidence.unboundmedicine.com/evidence/view/EBMG/451698/all/Intratympanic_gentamicin_for_Ménière's_disease
Intratympanic Gentamicin for Ménière's Disease [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2019 October 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/451698/all/Intratympanic_gentamicin_for_Ménière's_disease.
TY - ELEC
T1 - Intratympanic gentamicin for Ménière's disease
ID - 451698
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/451698/all/Intratympanic_gentamicin_for_Ménière's_disease
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine